23-24 September 2009
London, UK

With an exceptional line-up of speakers, SMi’s Biomarkers in Clinical Trials conference will demonstrate the way forward in designing phase I, II and III trials and present you with a fresh perspective on biomarker application in drug development.

This unique event is designed to help you realise the potential of your products in the most efficient way possible and is an essential addition to the calendar of all those working in the industry.

Attend and gain insights into the use of biomarkers as a way of accelerating the approval or withdrawal of a product. You will have the chance to network with industry associates and the opportunity to explore ways in which you can integrate biomarkers into your own drug development processes.

To find out more about the conference visit: www.smi-online.co.uk/biomarkers-ct1.asp

This conference will also be focusing on the following areas:

• Transfer of biomarkers to clinical practice
• Biomarkers in early clinical drug development
• Biomarkers in later stage clinical trials (phase II and III)
• Examples of successful use of biomarkers in clinical trials
• Potential for saving money by using biomarkers
• Biomarkers for disease modification in chronic disease
• Pre-clinical/clinical modeling
• Utilising positive and negative effect biomarkers in clinical trials

To take advantage of our early-bird discount, call Zain Philbey on +44 (0) 20 7827 6722 or email zphilbey@smi-online.co.uk